Table I Index
Table of Contents
Table I - 50 Marshall Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 188 | 343.5 | 92 | 381.9 | 96 | 322.8 |
Oral cavity and pharynx | * | # | * | # | * | # |
Lip | * | # | * | # | * | # |
Tongue | * | # | * | # | * | # |
Major salivary glands | * | # | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | * | # | * | # | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 42 | 73.8 | 21 | 85.6 | 21 | 66.2 |
Esophagus | * | # | * | # | * | # |
Stomach | 5 | 9.6** | * | # | * | # |
Small intestine | * | # | * | # | * | # |
Colon excluding rectum | 17 | 31.0** | 9 | 38.0** | 8 | 26.0** |
Rectum and rectosigmoid | 11 | 18.8** | 6 | 23.9** | 5 | 14.7** |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | * | # | * | # | * | # |
Gallbladder | * | # | * | # | * | # |
Other biliary | * | # | * | # | * | # |
Pancreas | * | # | * | # | * | # |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 35 | 68.3 | 26 | 111.7 | 9 | 33.9** |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | * | # | * | # | * | # |
Lung and bronchus | 33 | 64.0 | 24 | 102.8 | 9 | 33.9** |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | * | # | * | # | * | # |
Skin (excluding basal and squamous) | 7 | 13.4** | 5 | 19.5** | * | # |
Melanoma of the skin | 6 | 11.7** | * | # | * | # |
Other non-epithelial skin cancers | * | # | * | # | * | # |
Breast | 29 | 54.6 | * | # | 29 | 101.1 |
Female genital system | 17 | 28.6** | -- | -- | 17 | 52.7** |
Cervix uteri | * | # | -- | -- | * | # |
Corpus uteri | 11 | 18.9** | -- | -- | 11 | 34.6** |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | * | # | -- | -- | * | # |
Vagina | * | # | -- | -- | * | # |
Vulva | * | # | -- | -- | * | # |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 21 | 37.1 | 21 | 86.1 | -- | -- |
Prostate gland | 21 | 37.1 | 21 | 86.1 | -- | -- |
Testis | * | # | * | # | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 11 | 19.7** | 9 | 37.7** | * | # |
Urinary bladder | 9 | 16.1** | 7 | 29.7** | * | # |
Kidney and renal pelvis | * | # | * | # | * | # |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | * | # | * | # | * | # |
Brain | * | # | * | # | * | # |
Other nervous system | * | # | * | # | * | # |
Endocrine system | * | # | * | # | * | # |
Thyroid gland | * | # | * | # | * | # |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 5 | 9.1** | * | # | * | # |
Hodgkin’s disease | * | # | * | # | * | # |
Non-Hodgkin’s lymphoma | 5 | 9.1** | * | # | * | # |
Multiple myeloma | * | # | * | # | * | # |
Leukemia | 6 | 11.0** | * | # | * | # |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | * | # | * | # | * | # |
Acute myeloid | * | # | * | # | * | # |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | * | # | * | # | * | # |
Other, ill-defined and unknown sites | 8 | 13.8** | * | # | 6 | 17.9** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |